Updated on 10 January 2014
There is no suggestion that Diovan is ineffective in combating blood pressure problems.
Japan's pharmaceutical laws put that anyone found guilty of exaggerated advertising can be punished with up to two years in prison or a fine of as much as $19,400 (two million yen).
The ministry had concluded in September that Novartis Pharma KK should be held responsible for studies at various universities that used manipulated data on the drug.
Mr David Epstein, chief of Novartis Pharmaceuticals apologized for the concern the incident caused, but did not say that the company played any role in the allegations.